Allan Hackshaw
-
- Prenatal Screening and Diagnostics 30
- Infectious Diseases top 0.5%
- Parvovirus B19 Infection Studies 19
- Obstetrics and Gynecology top 1%
- Oncology top 1%
- Global Cancer Incidence and Screening 24
- Colorectal Cancer Screening and Detection 17
- Lung Cancer Research Studies 14
- Otorhinolaryngology top 2%
-
- Lung Cancer Treatments and Mutations 25
- Lung Cancer Diagnosis and Treatment 18
-
- Cancer Genomics and Diagnostics 14
Allan Hackshaw
188 papers receiving 10.2k citations
Hit Papers
Peers
Comparison fields: 5 of 181
- Pediatrics, Perinatology and Child Health 3.4k
- Infectious Diseases 1.7k
- Obstetrics and Gynecology 656
- Oncology 2.3k
- Otorhinolaryngology 240
Countries citing papers authored by Allan Hackshaw
This map shows the geographic impact of Allan Hackshaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allan Hackshaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allan Hackshaw more than expected).
Fields of papers citing papers by Allan Hackshaw
This network shows the impact of papers produced by Allan Hackshaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allan Hackshaw. The network helps show where Allan Hackshaw may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Allan Hackshaw, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 15 | |
| 7 | 2022 | 8 | |
| 8 | 2021 | 15 | |
| 9 | 2021 | 16 | |
| 10 | 2020 | 13 | |
| 11 | 2020 | 1 | |
| 12 | 2011 | 164 | |
| 13 | 2011 | 68 | |
| 14 | 2009 | 83 | |
| 15 | 2008 | 171 | |
| 16 | Large-scale prospective study reveals novel risk factors for Barrett's oesophagus | 2007 | 1 |
| 17 | A phase III randomised, double blind, placebo controlled trial of etoposide/carboplatin with or without thalidomide in advanced small cell lung cancer (SCLC) | 2007 | 6 |
| 18 | 2006 | 231 | |
| 19 | 2006 | 102 | |
| 20 | Prevention of migraine in the pill-free week of combined oral contraceptives using natural oestrogen supplements: A double-blind placebo controlled study | 2002 | 1 |
About Allan Hackshaw
Allan Hackshaw is a scholar working on Oncology, Obstetrics and Gynecology and Cancer Research, having authored 202 papers that have together received 10.7k indexed citations. Recurring topics across this work include Prenatal Screening and Diagnostics (30 papers), Lung Cancer Treatments and Mutations (25 papers), Global Cancer Incidence and Screening (24 papers), Parvovirus B19 Infection Studies (19 papers), Lung Cancer Diagnosis and Treatment (18 papers), Colorectal Cancer Screening and Detection (17 papers), Cancer Genomics and Diagnostics (14 papers) and Lung Cancer Research Studies (14 papers). The work is most often cited by research in Pediatrics, Perinatology and Child Health (3.4k citations), Infectious Diseases (1.7k citations) and Obstetrics and Gynecology (656 citations). Allan Hackshaw has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Nicholas Wald, M R Law, Charles H. Rodeck, Sadie Boniface, E. Anne MacGregor, Hilary Watt, Jocelyn Walters, Lyn S. Chitty, Anne Kennard and Jin-Ling Tang. Their work appears in journals such as Prenatal Diagnosis, Journal of Clinical Oncology, Annals of Oncology, Journal of Thoracic Oncology and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.